Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06348654

Not yet recruiting

New Digital Person-based Care Model in Patients With HER2-negative Advanced Breast Cancer (InPERSON)

Breast Cancer | Patient Satisfaction | Narrative Medicine | HER2-negative Breast Cancer
NCT06339658

Recruiting

ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy

Breast Cancer | Axillary Metastases
NCT06176534

Recruiting

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

Advanced Breast Cancer | Treatment | HR Low/HER2 Negative
NCT06065748

Recruiting

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT05918328

Recruiting

Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC

Breast Cancer | HER2-positive Breast Cancer
NCT05761470

Recruiting

Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation (IMPARP)

Her-2 Negative Breast Cancer | HRR Gene Mutation
NCT05753618

Recruiting

Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy (REaCT-OGF)

Early-stage Breast Cancer
NCT05044988

Not yet recruiting

A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer

HR+/HER2- Advanced and/or Metastatic Breast Cancer
NCT04997798

Recruiting

Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer

Breast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive Tumor
NCT04817540

Recruiting

Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)

HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study
NCT06343948

Active, not recruiting

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)

HR+HER2- Breast Cancer
NCT02705859

Completed

Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study) (Panther)

HER2 Positive Breast Cancer
NCT06710197

Withdrawn

IL-1 Inhibition in Early TNBC (OZM-034)

Early Stage Triple Negative ER Low Breast Cancer
NCT06705504

Completed

A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or Alpelisib

Hormone Receptor Positive HER-2 Negative Breast Cancer
NCT04983342

Completed

Apollo Device for Metastatic Breast Cancer (MBC)

Fatigue | Metastatic Breast Carcinoma
NCT02815852

Completed

RETROSPECTIVE ANALYSIS OF BREAST BIOPSIES IN WOMEN YOUNGER THAN 40 YEARS OLD (RAD2016)

Breast Cancer in Women Under 40 Years Old
NCT05995483

Active, not recruiting

Experimental Study With Pretest/Posttest Groups Which the Intervention Group Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day (BreastSelfExam)

Cancer | Breast Cancer | Nursing Caries | Awakening Early | Breast Self-Examination
NCT05189717

Enrolling by invitation

A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults

Metastatic or Local Advanced Breast Cancer of Patients
NCT03096847

Completed

Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer

Advanced Metastatic Breast Cancer
NCT02186015

Completed

Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D) (SAFE-D)

Metastatic Breast Cancer | Estrogen Receptor Positive | Adult Women
NCT03236974

Completed

Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer. (D6090C00002)

Postmenopausal Women With ER+ HER2- Primary Breast Cancer
NCT03797248

Unknown

Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer

Early-stage Breast Cancer
NCT04011085

Unknown

Tw HER2 Positive Breast Cancer Productivity & Utility Study

HER2-positive Breast Cancer
NCT03576521

Completed

Evaluation of Ocoxin®-Viusid® in Breast Cancer

Breast Cancer | Breast Carcinoma | Adriamycin Toxicity | Cyclosporine Toxicity
NCT01716247

Completed

Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer

Women at Increased Risk for Developing Breast Carcinoma
NCT00756132

Completed

Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca (Cyto-Cog)

Breast Cancer | Locally Advanced Breast Cancer
NCT00906321

Completed

Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk

Risk Reduction Behavior | High Risk for Breast Cancer
NCT01509625

Completed

Retrospective Study Assessment Treatment Response Faslodex®( 500 mg) (EFFICACY)

Malignant Neoplasm of Breast Stage IV
NCT01432223

Completed

Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab

Breast Cancer | Effects of Chemotherapy | HER-2 Positive Breast Cancer
NCT00212069

Completed

Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer

Metastatic Breast Cancer
NCT00162929

Completed

Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe) (AdHERe)

Metastatic Breast Cancer
NCT07583485

Recruiting

GIM27-THERapy: a Study to Describe the Effectiveness of Tucatinib in Combination With Capecitabine and Trastuzumab in the Treatment of Metastatic HER-2 Positive Breast Cancer Patients in Real World Setting (THERapy)

Breast Cancer
NCT07580105

Not yet recruiting

Clinical Study to Assess the Safety and Performance of Kenko Breast AI+ Medical Device as an Aid to Breast Cancer Diagnosis in Adult Women

Breast Cancer
NCT07574749

Recruiting

Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic Efficacy

Breast Cancer
NCT07562789

Not yet recruiting

Role of PCGEM1 in Breast Cancer

Breast Cancer
NCT07553234

Not yet recruiting

Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment (GEMMA)

Breast Cancer
NCT07543250

Not yet recruiting

A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer

Breast Cancer
NCT07532096

Not yet recruiting

Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer

Breast Cancer
NCT07528716

Not yet recruiting

Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy

Breast Cancer
NCT07528898

Not yet recruiting

Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.

Breast Cancer
NCT07502352

Not yet recruiting

Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)

Breast Cancer
NCT07474337

Recruiting

The Effect of Mindfulness-Based Breathing Exercises on Symptom Control

Breast Cancer
NCT07467330

Recruiting

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Breast Cancer
NCT07455955

Recruiting

Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile

Breast Cancer
NCT07441486

Not yet recruiting

A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer

Breast Cancer
NCT07436663

Not yet recruiting

Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC (SGLT2i/DPPi)

Breast Cancer
NCT07427407

Not yet recruiting

Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers

Breast Cancer
NCT07416253

Not yet recruiting

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

Breast Cancer
NCT07410234

Not yet recruiting

Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy

Breast Cancer
NCT07407153

Recruiting

Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound Device (Ultra-3 CBE)

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations